Last reviewed · How we verify

BB-12 supplemented strawberry yogurt

Georgetown University · Phase 1 active Small molecule Quality 5/100

BB-12 supplemented strawberry yogurt is a Small molecule drug developed by Georgetown University. It is currently in Phase 1 development.

At a glance

Generic nameBB-12 supplemented strawberry yogurt
SponsorGeorgetown University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about BB-12 supplemented strawberry yogurt

What is BB-12 supplemented strawberry yogurt?

BB-12 supplemented strawberry yogurt is a Small molecule drug developed by Georgetown University.

Who makes BB-12 supplemented strawberry yogurt?

BB-12 supplemented strawberry yogurt is developed by Georgetown University (see full Georgetown University pipeline at /company/georgetown-university).

What development phase is BB-12 supplemented strawberry yogurt in?

BB-12 supplemented strawberry yogurt is in Phase 1.

What are the side effects of BB-12 supplemented strawberry yogurt?

Common side effects of BB-12 supplemented strawberry yogurt include Loose Stools, Pain, Constipation, Nasal Congestion, Cough, Fever.

Related